The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia.
Watts B, Smith CM, Evans K, Gifford AJ, Mohamed SMA, Erickson SW, Earley EJ, Neuhauser S, Stearns TM, Philip VM, Chuang JH, Zweidler-McKay PA, Lakshmikanthan S, Jocoy EL, Bult CJ, Teicher BA, Smith MA, Lock RB.
Watts B, et al. Among authors: evans k.
Hemasphere. 2025 Jan 17;9(1):e70063. doi: 10.1002/hem3.70063. eCollection 2025 Jan.
Hemasphere. 2025.
PMID: 39830370
Free PMC article.